McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
43,000
Employees43,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
43,000
Employees43,000

MCK Key Statistics

Market cap
104.89B
Market cap104.89B
Price-Earnings ratio
24.38
Price-Earnings ratio24.38
Dividend yield
0.36%
Dividend yield0.36%
Average volume
880.46K
Average volume880.46K
High today
$907.50
High today$907.50
Low today
$883.59
Low today$883.59
Open price
$905.01
Open price$905.01
Volume
632.46K
Volume632.46K
52 Week high
$999.00
52 Week high$999.00
52 Week low
$687.68
52 Week low$687.68

Stock Snapshot

As of today, McKesson(MCK) shares are valued at $899.56. The company's market cap stands at 104.89B, with a P/E ratio of 24.38 and a dividend yield of 0.36%.

During the trading session on 2026-09-15, McKesson(MCK) shares reached a daily high of $907.50 and a low of $883.59. At a current price of $899.56, the stock is +1.8% higher than the low and still -0.9% under the high.

Trading activity shows a volume of 632.46K, compared to an average daily volume of 880.46K.

The stock's 52-week range extends from a low of $687.68 to a high of $999.00.

The stock's 52-week range extends from a low of $687.68 to a high of $999.00.

MCK News

Benzinga 1h
Here’s How Much You Would Have Made Owning McKesson Stock In The Last 5 Years - Benzinga

...

Here’s How Much You Would Have Made Owning McKesson Stock In The Last 5 Years - Benzinga
Simply Wall St 4h
Does Raised EPS Guidance Change The Bull Case For McKesson Stock?

McKesson recently raised its full-year EPS guidance, indicating expected growth of roughly 13% to 15%, or 15% to 17% excluding certain prior-year items. Manage...

Does Raised EPS Guidance Change The Bull Case For McKesson Stock?
Nasdaq 1d
McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal

McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its...

McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal

Analyst ratings

73%

of 22 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.